• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The "reset button" revisited: why high activity I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.

作者信息

Verburg Frederik A, Luster Markus, Giovanella Luca, Lassmann Michael, Chiesa Carlo, Chouin Nicolas, Flux Glenn

机构信息

Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16.

DOI:10.1007/s00259-017-3649-9
PMID:28210770
Abstract
摘要

相似文献

1
The "reset button" revisited: why high activity I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.再探“重置按钮”：为何剂量测定后对晚期分化型甲状腺癌进行高活性碘治疗对患者有益。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16.
2
[Problems of dosimetry posed by the utilization of radioactive iodine in the treatment of cancer of the thyroid].
J Radiol Electrol Arch Electr Medicale. 1954;35(1-2):22-7.
3
Sites Performing Dosimetry for Selection of Activity for I Therapy for Differentiated Thyroid Cancer.
J Nucl Med. 2019 Jun;60(6):20N-22N.
4
Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma.剂量测定法在分化型甲状腺癌¹³¹I治疗中的优势。
Q J Nucl Med Mol Imaging. 2019 Sep;63(3):253-257. doi: 10.23736/S1824-4785.19.03196-0. Epub 2019 Jul 1.
5
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.放射性碘剂量测定与转移性甲状腺癌治疗结果及并发症的关系。
Am J Roentgenol Radium Ther Nucl Med. 1962 Jan;87:171-82.
6
[Radioactive iodine and thyroid cancer].[放射性碘与甲状腺癌]
Ann Radiol (Paris). 1961;4:223-46.
7
Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?放射性碘剂量测定十年经验：它对转移性分化型甲状腺癌的治疗有帮助吗？
Clin Oncol (R Coll Radiol). 2017 May;29(5):310-315. doi: 10.1016/j.clon.2017.01.002. Epub 2017 Jan 27.
8
Radioiodine dosimetry in advanced thyroid cancer.晚期甲状腺癌的放射性碘剂量测定
Q J Nucl Med Mol Imaging. 2019 Sep;63(3):227-228. doi: 10.23736/S1824-4785.19.03209-6. Epub 2019 Jul 22.
9
Whole-remnant and maximum-voxel SPECT/CT dosimetry in I-NaI treatments of differentiated thyroid cancer.分化型甲状腺癌碘-碘化钠治疗中全残留和最大体素SPECT/CT剂量测定法
Med Phys. 2016 Oct;43(10):5279-5287. doi: 10.1118/1.4961742.
10
[Utilization of scintigraphy in the treatment of malignant tumors of the thyroid gland with radioactive iodine].
Vopr Onkol. 1962;8(7):38-43.

引用本文的文献

1
Evolving Paradigm in Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Historical Perspectives, Current Practices and Future Directions.分化型甲状腺癌放射性碘治疗的发展范式：历史回顾、当前实践与未来方向
Diagnostics (Basel). 2025 Jun 5;15(11):1438. doi: 10.3390/diagnostics15111438.
2
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.分化型甲状腺癌放射性碘治疗中的个体化剂量测定
Diagnostics (Basel). 2022 Jul 21;12(7):1763. doi: 10.3390/diagnostics12071763.
3
Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT.

本文引用的文献

1
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer.分化型甲状腺癌转移患者放射性碘治疗中经验性与基于全身/全血清除剂量测定法的比较
J Nucl Med. 2017 May;58(5):717-722. doi: 10.2967/jnumed.116.179606. Epub 2016 Oct 13.
2
Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imaging.应用 124I PET 显像评估分化型甲状腺癌初始碘-131 治疗后的病灶反应。
J Nucl Med. 2014 Nov;55(11):1759-65. doi: 10.2967/jnumed.114.144089. Epub 2014 Oct 20.
3
基于Choi、RECIST和生长抑素受体PET/CT标准对肽受体放射性核素治疗反应及反应预测的比较
Pharmaceutics. 2022 Jun 16;14(6):1278. doi: 10.3390/pharmaceutics14061278.
4
Perspectives for Concepts of Individualized Radionuclide Therapy, Molecular Radiotherapy, and Theranostic Approaches.个体化放射性核素治疗、分子放射治疗及诊疗一体化方法的概念展望。
Nucl Med Mol Imaging. 2019 Jun;53(3):167-171. doi: 10.1007/s13139-019-00586-x. Epub 2019 Jan 29.
5
Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy.使用多种内部剂量测定模型进行前瞻性剂量测定导向的放射性碘治疗的红骨髓剂量估计。
Radiat Environ Biophys. 2018 Nov;57(4):395-404. doi: 10.1007/s00411-018-0757-2. Epub 2018 Oct 8.
6
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.肿瘤核医学治疗中治疗优化与放射性药物固定活度剂量学登记之间的冲突。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1783-1786. doi: 10.1007/s00259-017-3707-3. Epub 2017 May 24.
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
患者处理方法：放射性碘治疗在儿童分化型甲状腺癌中的剂量学作用。
J Clin Endocrinol Metab. 2013 Oct;98(10):3912-9. doi: 10.1210/jc.2013-2259.
4
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.分化型甲状腺癌患者的预期寿命在诊断时存在广泛局部肿瘤侵犯、侧方淋巴结或远处转移（≥45 岁），以及所有其他 DTC 患者正常的情况下会降低。
J Clin Endocrinol Metab. 2013 Jan;98(1):172-80. doi: 10.1210/jc.2012-2458. Epub 2012 Nov 12.
5
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.甲状腺癌的低剂量碘 131 消融联合促甲状腺激素治疗。
N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.
6
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.低危甲状腺癌患者的碘 131 消融策略。
N Engl J Med. 2012 May 3;366(18):1663-73. doi: 10.1056/NEJMoa1108586.
7
Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer.剂量学与经验性 131I 规定活度治疗分化型甲状腺癌的疗效比较。
J Clin Endocrinol Metab. 2011 Oct;96(10):3217-25. doi: 10.1210/jc.2011-0494. Epub 2011 Aug 17.
8
The use of dosimetry in the treatment of differentiated thyroid cancer.剂量测定法在分化型甲状腺癌治疗中的应用。
Q J Nucl Med Mol Imaging. 2011 Apr;55(2):107-15.
9
Dosimetry and thyroid cancer: the individual dosage of radioiodine.剂量学与甲状腺癌：放射性碘的个体剂量。
Endocr Relat Cancer. 2010 Jun 3;17(3):R161-72. doi: 10.1677/ERC-10-0071. Print 2010 Sep.
10
Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.良性甲状腺疾病和分化型甲状腺癌的放射性碘治疗剂量测定
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):821-8. doi: 10.1007/s00259-010-1398-0.